Assessing the periprocedural magnitude of platelet count change in response to lusutrombopag

BACKGROUND & AIMS: Despite limitations, platelet transfusion has been used to minimise bleeding risk in patients with thrombocytopaenia. Lusutrombopag is an oral, thrombopoietin receptor agonist approved for treatment of thrombocytopaenia associated with chronic liver disease in patients undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Robert S., Imawari, Michio, Izumi, Namiki, Osaki, Yukio, Bentley, Roy, Ochiai, Toshimitsu, Kano, Takeshi, Peck-Radosavljevic, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887643/
https://www.ncbi.nlm.nih.gov/pubmed/33644726
http://dx.doi.org/10.1016/j.jhepr.2021.100228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887643/
https://www.ncbi.nlm.nih.gov/pubmed/33644726
http://dx.doi.org/10.1016/j.jhepr.2021.100228

Ejemplares similares